Skip to main content
NIH funding notice RFA-MH-21-112

Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional)

Closed on June 15, 2022.

Posted
November 13, 2020
Close date
June 15, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $756,966 in first-year total cost, median $378,483.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-D (03)]2

Most frequent institutions

  1. KSANA HEALTH, INC.1
  2. OUI THERAPEUTICS, INC1
Competing awards under RFA-MH-21-112 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022A Digital Psychoeducational Social Network Intervention for Suicidal Adolescents1R43MH128431-01A1SIMON, PATRICIAOUI THERAPEUTICS, INC, CT$453,596ZMH1
2022Development and testing of a digitally assisted risk reduction platform for youth at high risk for suicide1R44MH128484-01A1SCRIPA, PHILLIP ANTONYKSANA HEALTH, INC., OR$303,370ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-21-112: Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) | ScienceDex | ConductScience